Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

Isabelle Arnet; Melina Verbeek; Anna Birna Almarsdottir; Liese Barbier; Rhonda Clifford; Christiane Eickhoff; Kurt Hersberger; Isabelle Huys; Kenneth Lee; Kritsanee Saramunee; Martin Schulz; David Zgarrick; Kati Sarnola

doi:10.1016/j.rcsop.2021.100084

Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

Isabelle Arnet, Melina Verbeek, Anna Birna Almarsdottir, Liese Barbier, Rhonda Clifford, Christiane Eickhoff, Kurt Hersberger, Isabelle Huys, Kenneth Lee, Kritsanee Saramunee, Martin Schulz, David Zgarrick, Kati Sarnola

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.

Original language	English
Article number	100084
Journal	Exploratory Research in Clinical and Social Pharmacy
Volume	4
DOIs	https://doi.org/10.1016/j.rcsop.2021.100084
Publication status	Published - Dec 2021

Access to Document

10.1016/j.rcsop.2021.100084Licence: CC BY-NC-ND

Cite this

Arnet, I., Verbeek, M., Almarsdottir, A. B., Barbier, L., Clifford, R., Eickhoff, C., Hersberger, K., Huys, I., Lee, K., Saramunee, K., Schulz, M., Zgarrick, D., & Sarnola, K. (2021). Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey. Exploratory Research in Clinical and Social Pharmacy, 4, Article 100084. https://doi.org/10.1016/j.rcsop.2021.100084

@article{f6c329477c9b420bba5546097c804618,

title = "Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey",

abstract = "Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.",

author = "Isabelle Arnet and Melina Verbeek and Almarsdottir, {Anna Birna} and Liese Barbier and Rhonda Clifford and Christiane Eickhoff and Kurt Hersberger and Isabelle Huys and Kenneth Lee and Kritsanee Saramunee and Martin Schulz and David Zgarrick and Kati Sarnola",

year = "2021",

month = dec,

doi = "10.1016/j.rcsop.2021.100084",

language = "English",

volume = "4",

journal = "Exploratory Research in Clinical and Social Pharmacy",

issn = "2667-2766",

publisher = "Elsevier",

}

Arnet, I, Verbeek, M, Almarsdottir, AB, Barbier, L, Clifford, R, Eickhoff, C, Hersberger, K, Huys, I, Lee, K, Saramunee, K, Schulz, M, Zgarrick, D & Sarnola, K 2021, 'Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey', Exploratory Research in Clinical and Social Pharmacy, vol. 4, 100084. https://doi.org/10.1016/j.rcsop.2021.100084

TY - JOUR

T1 - Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

AU - Arnet, Isabelle

AU - Verbeek, Melina

AU - Almarsdottir, Anna Birna

AU - Barbier, Liese

AU - Clifford, Rhonda

AU - Eickhoff, Christiane

AU - Hersberger, Kurt

AU - Huys, Isabelle

AU - Lee, Kenneth

AU - Saramunee, Kritsanee

AU - Schulz, Martin

AU - Zgarrick, David

AU - Sarnola, Kati

PY - 2021/12

Y1 - 2021/12

N2 - Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.

AB - Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.

U2 - 10.1016/j.rcsop.2021.100084

DO - 10.1016/j.rcsop.2021.100084

M3 - Article

C2 - 35479848

SN - 2667-2766

VL - 4

JO - Exploratory Research in Clinical and Social Pharmacy

JF - Exploratory Research in Clinical and Social Pharmacy

M1 - 100084

ER -

Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

Abstract

Access to Document

Fingerprint

Cite this